BusinessSorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018By Nasdaq OMXMar 19, 2018, 12:00 PM UTC